A drug-Drug interaction study of Lanabecestat (LY3314814) in healthy participants

Trial Identifier:	16014
Sponsor:	AstraZeneca
Collaborator:	Eli Lilly and Company
NCTID::	NCT02406261
Start Date:	April 2015
Primary Completion Date:	August 2015
Study Completion Date:	August 2015
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
USA, Florida	Daytona Beach, Florida, USA, 32117
USA, TX	Dallas, TX, USA, 75247

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.